EXEL vs GMAB Stock Comparison

EXEL currently leads GMAB in this stock comparison, with AIQ scores of 82 vs 77. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 5 points
EXEL
Healthcare
vs
GMAB
Healthcare
EXEL
Exelixis, Inc.
Leads
Price
$69.00
Day move
-1.2%
AIQ Score
82/100
Best edge
Risk Resilience
Sector
Healthcare
GMAB
Genmab A/S
Price
$51.37
Day move
-0.72%
AIQ Score
77/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between EXEL and GMAB?

EXEL leads the current stock comparison as Exelixis, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Exelixis, Inc. vs Genmab A/S

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

EXEL leads

EXEL leads by 5 AIQ points, primarily on Risk Resilience and Value. Wall Street currently favors GMAB on target upside.

Fragile: 4 of 6 evidence groups support EXEL, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Stable
EXEL

Exelixis, Inc.

Leads
AIQ Score
82/100
AIQ Edge Score
10/10
GMAB

Genmab A/S

AIQ Score
77/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors EXEL over GMAB, 82 versus 77 as of Nov 15, 2026. EXEL's advantage is driven primarily by stronger risk resilience and value. EXEL also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors GMAB. 4 of 6 covered evidence groups favor EXEL today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 5 points. EXEL lead: Stable — the AIQ differential has held near 5 points over 30 sessions.

Compare Exelixis, Inc. and Genmab A/S across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

EXEL
+285.9%
GMAB
+20.6%

Price return comparison

Growth of $10,000, price only

EXEL $38,591 · GMAB $12,062

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare EXEL and GMAB against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

EXEL advantage
0
GMAB advantage
  • Risk Resilience77 vs 58
    EXEL +19
  • Value79 vs 71
    EXEL +8
  • Quality75 vs 72
    Even
  • Momentum91 vs 94
    Even

4 of 6 evidence groups favor EXEL. EXEL’s edge is concentrated in risk resilience and value.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

EXEL0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

GMAB-1 AIQ

No factor moved materially.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.57x)

EXEL's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — EXEL and GMAB both carry a full feed there.

The central trade-off

EXEL (Exelixis, Inc.): the stronger current systematic profile, led by risk resilience and value.

GMAB (Genmab A/S): the counter-case, on technicals, analyst expectations — but at materially higher volatility, 110.9% against 34.5%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

EXEL

EXEL on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

GMAB

GMAB on combined revenue and EPS growth.

Value

EXEL

EXEL on the peer-relative Value factor, by 8 points.

Momentum

Even

The two are level on Momentum.

Lower downside

EXEL

EXEL on Risk Resilience, by 19 points.

Analyst upside

GMAB

GMAB on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors EXEL, analyst targets favor GMAB. That disagreement is the most useful thing on this page.

MeasureEXELGMABNote
Implied upside to target-15%+8%GMAB has more room
Target dispersion+23.9%+50.5%Lower is tighter analyst agreement
ConsensusHoldBuyContext, not a primary driver
Analysts covering1713Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor EXEL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEXEL82 vs 77
FundamentalsEXELon balancerevenue growth 4.8% vs 2.8%; EPS growth 3.5% vs 14.3%; TTM ROE 11.9% vs 5.4%; gross margin 96.3% vs 92.6%; operating margin 40.2% vs 30.5% — EXEL takes 4 of 5 decided legs, not all of them
ValuationEXELValue 79 vs 71
TechnicalsGMABPrice vs 50-day 10.8% vs 24.8%; vs 200-day 32.1% vs 62.9%
Risk ResilienceEXELRisk Resilience 77 vs 58
Analyst expectationsGMABTarget upside -15% vs 8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of EXEL and GMAB and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 5 points. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on EXEL.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

EXEL lead: Stable — the AIQ differential has held near 5 points over 30 sessions.

May 27EXEL leads above the line · GMAB leads belowNov 13
Today
EXEL +5
82 vs 77
7 sessions ago
EXEL +3
82 vs 79
30 sessions ago
EXEL +3
80 vs 77
90 sessions ago
EXEL +6
74 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

EXELConflicted

3 bullish / 3 bearish, conflicted

No signal that the other name lacks.

GMABConflicted

3 bullish / 3 bearish / 1 neutral, conflicted

Only GMAB

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.51%)

Both carry 6 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, MACD Histogram Expanding Bearish, RSI Bearish Divergence, Uptrend Structure Active.

EXEL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

EXELNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.2%, AIQ 0 points).

GMABConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -0.72%, AIQ -1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1GMAB closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to EXEL's edge.
  2. 2GMAB's Low Volume Rally Warning resolves — a bearish volume rule currently active against it.
  3. 3EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

EXEL leads on balance
MetricEXELGMAB
Revenue growth (YoY)4.8%2.8%
EPS growth (YoY)3.5%14.3%
Gross margin96.3%92.6%
Operating margin40.2%30.5%
Return on equity (TTM)11.9%5.4%
Debt to equity0.090.82

Performance

GMAB leads 5 of 6 windows
MetricEXELGMAB
1 week (5 sessions)-0.8%-4.2%
1 month (20 sessions)10.9%38.8%
3 months (63 sessions)31.9%56.4%
6 months (126 sessions)37.6%93.6%
Year to date57.4%66.8%
1 year (252 sessions)58.3%68.6%

Technicals

GMAB has the stronger structure
MetricEXELGMAB
RSI (14)58.659.1
ADX (14)40.845.8
Price vs 50-day10.8%24.8%
Price vs 200-day32.1%62.9%
Volatility (1M, annualized)34.5%110.9%

Risk

EXEL is the more resilient
MetricEXELGMAB
Beta0.610.93
Sharpe ratio1.51.29
Sortino ratio2.322.53
Max drawdown-12.6%-32.5%
Current drawdown-5.2%-10.3%
Annualized volatility33.9%45.9%
Value at risk (95%)-2.8%-3.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, EXEL or GMAB?

On the Algovestiq AIQ Score, EXEL is the stronger of the two as of Nov 15, 2026, scoring 82 against GMAB's 77. The edge comes from risk resilience and value. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is EXEL or GMAB the better buy right now?

EXEL carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 5 points. Treat the lead as provisional.

Why does the AIQ Score favor EXEL over GMAB?

The composite weights Quality, Value, Momentum and Risk Resilience. EXEL leads Risk Resilience by 19 points; EXEL leads Value by 8 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, EXEL or GMAB?

Analyst price targets imply -15% upside for EXEL and +8% for GMAB, so the Street currently favors GMAB. That points the opposite way to the AIQ Score, which favors EXEL. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, EXEL or GMAB?

EXEL is the better-valued of the two on the peer-relative Value factor. EXEL on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, EXEL or GMAB?

GMAB on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, EXEL or GMAB?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, EXEL or GMAB?

EXEL is the more resilient of the two, so the other name carries the higher downside risk. EXEL on Risk Resilience, by 19 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is EXEL more profitable than GMAB?

EXEL leads on the comparable margin measures — gross margin 96.3% vs 92.6%; operating margin 40.2% vs 30.5%; ttm roe 11.9% vs 5.4%.

Is EXEL's lead over GMAB getting stronger or weaker?

EXEL lead: Stable — the AIQ differential has held near 5 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the EXEL vs GMAB verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: GMAB closes the Risk Resilience gap — currently 19 points behind, the largest single contributor to EXEL's edge; GMAB's Low Volume Rally Warning resolves — a bearish volume rule currently active against it; EXEL's conflicting signal state resolves bearish — it currently carries 3 bullish and 3 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about EXEL and GMAB?

EXEL: 3 bullish / 3 bearish, conflicted. GMAB: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on EXEL is Golden Cross Active (bullish, long horizon). On GMAB it is Golden Cross Active (bullish, long horizon).

Compare EXEL and GMAB with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.